Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better - Lan Zhu; Lei Zhang; Wenjun Shang; Wenhua Liu; Rula Sa; Zhiliang Guo; Longshan Liu; Jinghong Tan; Hengxi Zhang; Yonghua Feng; Wenyu Zhao; Wenqi Cong; et al. (Chinese Medical Journal)